These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 12374431)

  • 1. Is Alzheimer's disease a mitochondrial disorder?
    Cash AD; Perry G; Ogawa O; Raina AK; Zhu X; Smith MA
    Neuroscientist; 2002 Oct; 8(5):489-96. PubMed ID: 12374431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease.
    Smith MA; Nunomura A; Zhu X; Takeda A; Perry G
    Antioxid Redox Signal; 2000; 2(3):413-20. PubMed ID: 11229355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mitochondria and vascular lesions as a central target for the development of Alzheimer's disease and Alzheimer disease-like pathology in transgenic mice.
    Aliev G; Seyidova D; Lamb BT; Obrenovich ME; Siedlak SL; Vinters HV; Friedland RP; LaManna JC; Smith MA; Perry G
    Neurol Res; 2003 Sep; 25(6):665-74. PubMed ID: 14503022
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondria are a direct site of A beta accumulation in Alzheimer's disease neurons: implications for free radical generation and oxidative damage in disease progression.
    Manczak M; Anekonda TS; Henson E; Park BS; Quinn J; Reddy PH
    Hum Mol Genet; 2006 May; 15(9):1437-49. PubMed ID: 16551656
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial alterations, oxidative stress and neuroinflammation in Alzheimer's disease.
    Verri M; Pastoris O; Dossena M; Aquilani R; Guerriero F; Cuzzoni G; Venturini L; Ricevuti G; Bongiorno AI
    Int J Immunopathol Pharmacol; 2012; 25(2):345-53. PubMed ID: 22697066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidative stress hypothesis in Alzheimer's disease.
    Markesbery WR
    Free Radic Biol Med; 1997; 23(1):134-47. PubMed ID: 9165306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oxidative damage in Alzheimer's disease: the metabolic dimension.
    Perry G; Nunomura A; Hirai K; Takeda A; Aliev G; Smith MA
    Int J Dev Neurosci; 2000; 18(4-5):417-21. PubMed ID: 10817925
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Oxidative damage in the olfactory system in Alzheimer's disease.
    Perry G; Castellani RJ; Smith MA; Harris PL; Kubat Z; Ghanbari K; Jones PK; Cordone G; Tabaton M; Wolozin B; Ghanbari H
    Acta Neuropathol; 2003 Dec; 106(6):552-6. PubMed ID: 12955399
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyloid precursor protein-mediated free radicals and oxidative damage: implications for the development and progression of Alzheimer's disease.
    Reddy PH
    J Neurochem; 2006 Jan; 96(1):1-13. PubMed ID: 16305625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain mitochondria as a primary target in the development of treatment strategies for Alzheimer disease.
    Aliev G; Palacios HH; Walrafen B; Lipsitt AE; Obrenovich ME; Morales L
    Int J Biochem Cell Biol; 2009 Oct; 41(10):1989-2004. PubMed ID: 19703659
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sources and mechanisms of cytoplasmic oxidative damage in Alzheimer's disease.
    Marlatt M; Lee HG; Perry G; Smith MA; Zhu X
    Acta Neurobiol Exp (Wars); 2004; 64(1):81-7. PubMed ID: 15190682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mitochondrial abnormalities in Alzheimer's disease.
    Hirai K; Aliev G; Nunomura A; Fujioka H; Russell RL; Atwood CS; Johnson AB; Kress Y; Vinters HV; Tabaton M; Shimohama S; Cash AD; Siedlak SL; Harris PL; Jones PK; Petersen RB; Perry G; Smith MA
    J Neurosci; 2001 May; 21(9):3017-23. PubMed ID: 11312286
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oxidative stress, mitochondrial dysfunction, and stress signaling in Alzheimer's disease.
    Onyango IG; Khan SM
    Curr Alzheimer Res; 2006 Sep; 3(4):339-49. PubMed ID: 17017864
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondrial Dysfunction in Neocortex and Hippocampus of Olfactory Bulbectomized Mice, a Model of Alzheimer's Disease.
    Avetisyan AV; Samokhin AN; Alexandrova IY; Zinovkin RA; Simonyan RA; Bobkova NV
    Biochemistry (Mosc); 2016 Jun; 81(6):615-23. PubMed ID: 27301290
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mitochondrial control of autophagic lysosomal pathway in Alzheimer's disease.
    Cardoso SM; Pereira CF; Moreira PI; Arduino DM; Esteves AR; Oliveira CR
    Exp Neurol; 2010 Jun; 223(2):294-8. PubMed ID: 19559703
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of abnormal mitochondrial dynamics in the pathogenesis of Alzheimer's disease.
    Wang X; Su B; Zheng L; Perry G; Smith MA; Zhu X
    J Neurochem; 2009 May; 109 Suppl 1(Suppl 1):153-9. PubMed ID: 19393022
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial abnormalities and oxidative imbalance in Alzheimer disease.
    Zhu X; Perry G; Moreira PI; Aliev G; Cash AD; Hirai K; Smith MA
    J Alzheimers Dis; 2006 Jul; 9(2):147-53. PubMed ID: 16873962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oxidative imbalance in Alzheimer's disease.
    Zhu X; Lee HG; Casadesus G; Avila J; Drew K; Perry G; Smith MA
    Mol Neurobiol; 2005; 31(1-3):205-17. PubMed ID: 15953822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of mitochondrial dysfunction in Alzheimer's disease.
    Castellani R; Hirai K; Aliev G; Drew KL; Nunomura A; Takeda A; Cash AD; Obrenovich ME; Perry G; Smith MA
    J Neurosci Res; 2002 Nov; 70(3):357-60. PubMed ID: 12391597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cerebrometabolic abnormalities in Alzheimer's disease.
    Blass JP
    Neurol Res; 2003 Sep; 25(6):556-66. PubMed ID: 14503009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.